157 related articles for article (PubMed ID: 8321327)
1. Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.
Niiya K; Jacobson KA; Silvia SK; Olsson RA
Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):521-6. PubMed ID: 8321327
[TBL] [Abstract][Full Text] [Related]
2. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
3. Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node.
Dennis D; Jacobson K; Belardinelli L
Am J Physiol; 1992 Mar; 262(3 Pt 2):H661-71. PubMed ID: 1558173
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
Jacobson KA; Stiles GL; Ji XD
Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
[TBL] [Abstract][Full Text] [Related]
5. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.
Vials A; Burnstock G
Br J Pharmacol; 1993 Jun; 109(2):424-9. PubMed ID: 8358543
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.
Nikodijević O; Sarges R; Daly JW; Jacobson KA
J Pharmacol Exp Ther; 1991 Oct; 259(1):286-94. PubMed ID: 1920121
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of three adenosine receptor types.
Gurden MF; Coates J; Ellis F; Evans B; Foster M; Hornby E; Kennedy I; Martin DP; Strong P; Vardey CJ
Br J Pharmacol; 1993 Jul; 109(3):693-8. PubMed ID: 8358566
[TBL] [Abstract][Full Text] [Related]
8. The A2A adenosine receptor mediates coronary vasodilation.
Belardinelli L; Shryock JC; Snowdy S; Zhang Y; Monopoli A; Lozza G; Ongini E; Olsson RA; Dennis DM
J Pharmacol Exp Ther; 1998 Mar; 284(3):1066-73. PubMed ID: 9495868
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart.
Shryock JC; Travagli HC; Belardinelli L
J Pharmacol Exp Ther; 1992 Mar; 260(3):1292-9. PubMed ID: 1545393
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
Felsch A; Stöcker K; Borchard U
Eur J Pharmacol; 1994 Oct; 263(3):261-8. PubMed ID: 7843263
[TBL] [Abstract][Full Text] [Related]
11. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.
Gao Z; Li Z; Baker SP; Lasley RD; Meyer S; Elzein E; Palle V; Zablocki JA; Blackburn B; Belardinelli L
J Pharmacol Exp Ther; 2001 Jul; 298(1):209-18. PubMed ID: 11408544
[TBL] [Abstract][Full Text] [Related]
12. Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.
Zhang J; Belardinelli L; Jacobson KA; Otero DH; Baker SP
Mol Pharmacol; 1997 Sep; 52(3):491-8. PubMed ID: 9281612
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of adenosines, but not adenosine receptors, differ in rat and guinea pig.
Ueeda M; Thompson RD; Padgett WL; Secunda S; Daly JW; Olsson RA
Life Sci; 1991; 49(18):1351-8. PubMed ID: 1921650
[TBL] [Abstract][Full Text] [Related]
14. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
15. 2-(N'-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators.
Niiya K; Thompson RD; Silvia SK; Olsson RA
J Med Chem; 1992 Nov; 35(24):4562-6. PubMed ID: 1469688
[TBL] [Abstract][Full Text] [Related]
16. Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart.
Erga KS; Seubert CN; Liang HX; Wu L; Shryock JC; Belardinelli L
Br J Pharmacol; 2000 Jul; 130(5):1065-75. PubMed ID: 10882391
[TBL] [Abstract][Full Text] [Related]
17. 2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
Ueeda M; Thompson RD; Arroyo LH; Olsson RA
J Med Chem; 1991 Apr; 34(4):1340-4. PubMed ID: 2016708
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the adenosine receptor in porcine coronary arteries.
King AD; Milavec-Krizman M; Müller-Schweinitzer E
Br J Pharmacol; 1990 Jul; 100(3):483-6. PubMed ID: 2390673
[TBL] [Abstract][Full Text] [Related]
19. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
Conti A; Lozza G; Monopoli A
Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
[TBL] [Abstract][Full Text] [Related]
20. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
